ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,998,456 | -17.4% | 666,152 | +3.0% | 0.00% | – |
| Q2 2023 | $2,418,819 | +2.4% | 646,743 | -8.3% | 0.00% | – |
| Q1 2023 | $2,361,897 | -30.9% | 705,044 | -0.8% | 0.00% | -100.0% |
| Q4 2022 | $3,419,612 | -17.1% | 710,938 | -2.0% | 0.00% | 0.0% |
| Q3 2022 | $4,127,000 | -16.1% | 725,226 | +4.6% | 0.00% | 0.0% |
| Q2 2022 | $4,921,000 | +21.7% | 693,126 | +23.8% | 0.00% | 0.0% |
| Q1 2022 | $4,043,000 | -21.4% | 560,020 | -2.7% | 0.00% | 0.0% |
| Q4 2021 | $5,143,000 | -75.2% | 575,268 | -2.7% | 0.00% | -75.0% |
| Q3 2021 | $20,733,000 | +85.5% | 591,361 | +13.6% | 0.00% | +100.0% |
| Q2 2021 | $11,179,000 | +8.3% | 520,422 | +211.3% | 0.00% | 0.0% |
| Q1 2021 | $10,321,000 | +39.6% | 167,160 | -5.5% | 0.00% | +100.0% |
| Q4 2020 | $7,391,000 | – | 176,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |